Application 204528
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMIVUDINE | LAMIVUDINE | TABLET;ORAL | 150MG | No | No |
| 002 | LAMIVUDINE | LAMIVUDINE | TABLET;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204528-001 | LAMIVUDINE | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | ||
| A204528-002 | LAMIVUDINE | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204528-001 | LAMIVUDINE | 150MG | TABLET / ORAL | 2016-03-04 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204528-002 | LAMIVUDINE | 300MG | TABLET / ORAL | 2016-03-04 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 6bd6b9da-df69-46db-813e-4e7f3bdecf95 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Major Pharmaceuticals | 6fd4d6b9-65ea-4988-8d6f-dd220ec5052d | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Strides Pharma Science Limited | ac824c7e-9c9f-487b-ad2f-d50eaef5cbda | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| lamivudine | LAMIVUDINE ORAL | Chartwell Govermental & Specialty RX, LLC. | b23aea53-324b-4ff2-8736-639e4045e388 | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | lamivudine |
| lamivudine | LAMIVUDINE ORAL | Chartwell RX, LLC | ef9977cb-ec91-46d7-b769-d26decfd6fe7 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | lamivudine |
| LAMIVUDINE | LAMIVUDINE | Golden State Medical Supply, Inc. | f3637209-303e-4232-ae79-07315a990973 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Apotex Corp. | 34c02bcc-d6ff-99d4-8e6a-4a91908adca8 | 2025-09-19 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Golden State Medical Supply, Inc. | 3c30216d-f9f5-104b-e063-6294a90af8fd | 2025-08-12 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Apotex Corp. | 87095352-c088-74b1-7be0-d3e293a90611 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Coupler LLC | 2d7db3b2-9b3c-3031-e063-6294a90a342c | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | e90671c6-7fff-48f4-8898-29f02d049c8b | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 49d53e74-3798-4463-b817-1c8beb755034 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | American Health Packaging | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | a8a492ab-396a-4b7c-99b3-bcb6d3386f71 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Rising Pharma Holdings, Inc. | bed2e227-8d36-40ea-bbbf-d8793bfda425 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | ba7ee31e-e8d4-4e17-b27a-d2ce69e3bb00 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Lupin Pharmaceuticals, Inc. | ff3b5265-f533-4332-a861-d8c9c1664ffd | 2024-01-03 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Macleods Pharmaceuticals Limited | 1be30bcc-2d9f-4afc-8f09-adc840b3f2d9 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Ingenus Pharmaceuticals, LLC | 47f8be59-178c-4bad-96a4-a5c82784f308 | 2018-12-24 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70518-0513 | Lamivudine | lamivudine | REMEDYREPACK INC. | ANDA | Current |
| 70518-0540 | Lamivudine | lamivudine | REMEDYREPACK INC. | ANDA | Current |